Key Points
Mumbai (Maharashtra) [India], April 20 (ANI): Tuberculosis (TB) remains a formidable global health challenge, with over 2.95 million active cases reported in India alone in 2020...
Among these cases, 135,000 were classified as multidrug-resistant TB (MDR-TB), posing a significant threat to treatment efficacy and control efforts...
HaystackAnalytics, partnered with Dr DY Patil Medical College, Pune, conducted a study shedding new light on TB dynamics in India...
Dr Anirvan Chatterjee, CEO and Co-founder at HaystackAnalytics and a contributor to the study, emphasized the need for tailored TB management strategies, India bears 27 per cent of the total TB cases in the world, according to the Global TB Report 2023 by WHO..
Dr Chatterjee further stressed the importance of educating healthcare professionals and patients on the use of diagnostic technologies like whole-genome sequencing (WGS) and Cartridge-Based Nucleic Acid Amplification Test (CBNAAT), especially amidst emerging resistance to newer drugs like bedaquiline..
You might be interested in
Whole genome sequencing could be key to detecting drug-resistant TB, shows study
21, Apr, 24India faces challenges because of low investment in public health programs, high endemicity in difficult-to-reach locations, and persisting diagnostic gaps.